Mechanistic studies are needed and should include assessment of circulating endothelial progenitor cells and regulatory T cells by flow cytometry.

In contrast, the predicted minimal median DFI for all treated dogs was 410 days. A veterinary society of surgical oncology retrospective study, Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma, Journal of the American Veterinary Medical Association, Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part of a chemotherapeutic treatment for lymphoma: 57 cases (2007–2012), Journal of the American Veterinary Medical Association, Withrow and MacEwen's Small Animal Clinical Oncology, Withrow and MacEwen's Small Animal Clinical Oncology, A novel approach to treatment of lymphangiosarcoma in a boxer dog, Vaginal discharge in a spayed dog with multiple distinct malignancies, Retrospective evaluation of doxorubicin–piroxicam combination for the treatment of transitional cell carcinoma in dogs, Risk factors for development of sterile haemorrhagic cystitis in canine lymphoma patients receiving oral cyclophosphamide: a case–control study, Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?, Clinical and Immunomodulatory Effects of Toceranib Combined with Low‐Dose Cyclophosphamide in Dogs with Cancer, First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study, Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer, Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour‐bearing dogs (excluding mast cell tumours): a phase I dose‐finding study, Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas, Low‐Dose Cyclophosphamide Selectively Decreases Regulatory T Cells and Inhibits Angiogenesis in Dogs with Soft Tissue Sarcoma, Tolerability of Metronomic Administration of Lomustine in Dogs with Cancer, Canine Cutaneous Perivascular Wall Tumors at First Presentation: Clinical Behavior and Prognostic Factors in 55 Cases, Prognostic Factors for Cutaneous and Subcutaneous Soft Tissue Sarcomas in Dogs, “Metronomic” chemotherapy in advanced soft tissue sarcomas, Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy,

In dogs with gastrointestinal or renal adverse effects, increasing the treatment interval to every other day dosing of both drugs usually was effective in resolving the adverse effects.

Although all dogs in this study had evidence of incomplete tumor resection (ie, microscopic evidence of tumor cells at the margins of the resected tumor tissue), we considered the skill of the surgeon to be an important variable in this study. Cyclophosphamide is a nitrogen mustard based agent medication and will have 2 main effects:The drug is only available through prescription.

, Drug repurposing in oncology—patient and health systems opportunities, Current Concepts in Oncologic Surgery in Small Animals, Veterinary Clinics of North America: Small Animal Practice, Intradural–extramedullary haemangioblastoma with paraspinal extension in a dog, Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study, Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma, Clinical Studies of Metronomic Chemotherapy in Dogs, Metronomic Chemotherapy in Veterinary Patients with Cancer, Veterinary Clinics of North America: Small Animal Practice, Evaluation of low-dose metronomic (LDM) cyclophosphamide toxicity in cats with malignant neoplasia, Tolerability of Lomustine in Combination with Cyclophosphamide in Dogs with Lymphoma, Journal of the American Animal Hospital Association, Cyclophosphamide intoxication because of pharmacy error in two dogs, Journal of the American Veterinary Medical Association, Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs – a retrospective study, High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors, Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005–2012), Journal of the American Veterinary Medical Association, Nonsteroidal Anti‐Inflammatory Drugs and Corticosteroids, Evaluation of toxicities from combined metronomic and maximal‐tolerated dose chemotherapy in dogs with osteosarcoma, Phase I/II Clinical Trial of Encapsulated, Cytochrome P450 Expressing Cells as Local Activators of Cyclophosphamide to Treat Spontaneous Canine Tumours, Effects of low‐dose cyclophosphamide with piroxicam on tumour neovascularization in a canine oral malignant melanoma‐xenografted mouse model, Hemipelvectomy: Outcome in 84 dogs and 16 cats.

The dosage of CYC was chosen based on our recent investigation of the effects of CYC on Treg numbers in the blood of dogs with soft tissue sarcoma.